Abstract
The mechanism underlying blood pressure (BP) reduction in the high fruits and vegetables arm of the Dietary Approaches to Stop Hypertension (DASH) study is unknown but may include potassium, magnesium and fibre. This study was designed to separate minerals and fibre from other components of DASH on BP in abdominally obese individuals with metabolic syndrome with pre-hypertension to stage 1 hypertension (obese hypertensives). A total of 15 obese hypertensives and 15 lean normotensives were studied on a standardized usual diet, randomized to DASH or usual diet supplemented with potassium, magnesium and fibre to match DASH, then crossed over to the complementary diet. All diets were 3 weeks long, isocaloric and matched for sodium and calcium. In obese hypertensives, BP was lower after 3 weeks on DASH than usual diet (−7.6±1.4/−5.3±1.4 mm Hg, P<0.001/0.02) and usual diet supplemented (−6.2±1.4/−3.7±1.4 P<0.005/0.06), whereas BP was not significantly different on usual and supplemented diets. BP values were not different among the three diets in lean normotensives. Small artery elasticity was lower in obese hypertensives than in lean normotensives on the usual and supplemented diets (P<0.02). This index of endothelial function improved in obese hypertensives (P<0.02) but not lean normotensives on DASH, and was no longer different from values in lean normotensives (P>0.50). DASH is more effective than potassium, magnesium and fibre supplements for lowering BP in obese hypertensives, which suggest that high fruits and vegetables DASH lowers BP and improves endothelial function in this group by nutritional factors in addition to potassium, magnesium and fibre.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Flegal KM, Carroll MD, Ogden CL, Johnson CL . Prevalence and trends in obesity among US adults, 1999—2000. JAMA 2002; 288: 1723–1727.
Wang Y, Wang Q-J . The prevalence of prehypertension and hypertension among US adults according to the new Joint National Committee Guidelines: new challenges of the old problem. Arch Intern Med 2004; 164: 2126–2134.
Egan BM . Should metabolic syndrome patients with pre-hypertension receive antihypertensive therapy? In: GL Bakris (eds). Therapeutic Strategies in Hypertension. Clin Publ: Oxford, UK, 2006; ch 2, pp 9–25.
Case CC, Jones PH, Nelson K, O'Brian Smith E, Ballantyne CM . Impact of weight loss on the metabolic syndrome. Diabetes Obes Metab 2002; 4: 407–414.
Mark AL . Weight reduction for treatment of obesity-associated hypertension: nuances and challenges. Curr Hypertens Rep 2007; 9: 368–372.
Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM et al. A clinical trial of the effects of dietary patterns on blood pressure: DASH Collaborative Research Group. N Engl J Med 1997; 336: 1117–1124.
He FJ, Markandu ND, Coltart R, Barron J, MacGregor GA . Effect of short-term supplementation of potassium chloride and potassium citrate on blood pressure in hypertensives. Hypertension 2005; 45: 571–574.
Jee SH, Miller ER, Guallar E, Singh VK, Appel LJ, Klag MJ . The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertension 2002; 15: 691–696.
Streppel MT, Arends LR, van't Veer P, Grobbee DE, Gelenijnse JM . Dietary fiber and blood pressure: a meta-analysis of randomized placebo-controlled trials. Arch Intern Med 2005; 9: 95–97.
Pou KM, Massaro JM, Hoffman U, Vasan RS, Maurovich-Horvat P, Larson MG et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: The Framingham Heart Study. Circulation 2007; 116: 1234–1241.
Van Guilder GP, Hoetzer GL, Greiner JJ, Stauffer BL, Desouza CA . Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults. Obesity 2006; 14: 2127–2131.
Vincent HK, Innes KE, Vincent KR . Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity. Diabetes Obes Metab 2007; 9: 813–839.
Meyer MR, Gokce N . Endothelial dysfunction in obesity: etiological role in atherosclerosis. Curr Opin Endrocinol Diab Obes 2007; 14: 365–369.
Lopes HF, Martin KL, Nashar K, Morrow JD, Goodfriend TL, Egan BM . DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity. Hypertension 2003; 41: 422–430.
Whelton PK, Kumanyika SK, Cook NR, Cutler JA, Borhani NO, Hennekens CH et al. Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the trials of hypertension prevention. Trials of Hypertension Prevention Collaborative Group. Am J Clin Nutr 1997; 65 (Suppl 2): 652S–660S.
Beyer FR, Dickinson HO, Nicolson DJ, Ford GA, Mason J . Combined calcium, magnesium and potassium supplementation for the management of primary hypertension in adults. Coch Data Sys Rev 2006; 3: CDC004805.
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735–2752.
Schakel S, Buzzard I, Gebhardt S . Procedures for estimating nutrient values for food composition databases. J Food Compost Anal 1997; 10: 102–114.
Harris J, Benedict F . A biometric study of human basal metabolism. Proc Natl Acad Sci USA 1918; 4: 370–373.
Simmons SF, Reuben D . Nutritional intake monitoring for nursing home residents: a comparison of staff documentation, direct observation, and photography methods. J Am Ger Soc 2000; 48: 209–213.
McVeigh GE, Bratteli CW, Morgan DJ, Alinder CM, Glasser SP, Finkelstein SM et al. Age-related abnormalities in arterial compliance identified by pressure pulse contour analysis: aging and arterial compliance. Hypertension 1999; 33: 1392–1398.
Lemogoum D, Flores G, Van den Abeele W, Ciarka A, Leeman M, Dagaute JP et al. Validity of pulse pressure and augmentation index as surrogate measures of arterial stiffness during beta-adrenergic stimulation. J Hypertens 2004; 22: 511–517.
Besch W, Woltanski KP, Keilacker H, Diaz-Alonso JM, Schulz B, Amendt P et al. Measurement of insulin in human sera using a new RIA kit, 1: insulin determination in the absence of insulin antibodies—conventional assay and micro modification. Exp Clin Endocrinol 1987; 90: 264–270.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC . Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.
De Bruin TW, Brouwer CB, Gimpel JA, Erkelens DW . Postprandial decrease in HDL cholesterol and HDL apo A-I in normal subjects in relation to triglyceride metabolism. Am J Physiol 1991; 260: E492–E498.
Friedewald WT, Levy RI, Fredrickson DS . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.
Houston MC . Nutraceuticals, vitamins, antioxidants, and minerals in the prevention and treatment of hypertension. Prog Cardiovasc Dis 2005; 47: 396–449.
Moline J, Bukharovich IF, Wolff MS, Phillips R . Dietary flavonoids and hypertension: is there a link? Med Hypotheses 2000; 55: 306–309.
Elliott P, Stamler J, Nichol R, Dyer AR, Stamler R, Kesteloot H et al. Intersalt revisited: further analyses of 24-h sodium excretion and blood pressure within and across populations. Intersalt Cooperative Research Group. Br Med J 1996; 312: 1249–1253.
Dickinson HO, Nicolson DJ, Cook JV, Campbell F, Beyer FR, Ford GA et al. Calcium supplementation for the management of primary hypertension in adults. Coch Data Sys Rev 2006; 2: CD004639.
Bucher HC, Cook RJ, Guyatt GH, Lang JD, Cook DJ, Hatala R et al. Effects of dietary calcium supplementation on blood pressure: a meta-analysis of randomized controlled trials. JAMA 1996; 275: 1016–1022.
McVeigh GE, Bratteli CW, Morgan DJ, Alinder CM, Glasser SP, Finkelstein SM et al. Age-related abnormalities in arterial compliance identified by pressure pulse contour analysis: aging and arterial compliance. Hypertension 1999; 33: 1392–1398.
Stojiljkovic MP, Zhang D, Lopes HF, Lee CG, Goodfriend TL, Egan BM . Hemodynamic effects of lipids in humans. Am J Physiol 2001; R280: 1674–1679.
Davda RK, Stepniakowski KT, Lu G, Ullian ME, Goodfriend TL, Egan BM . Oleic acid inhibits endothelial cell nitric oxide synthase by a PKC-independent mechanism. Hypertension 1995; 26: 764–770.
Lu G, Greene EL, Nagai T, Egan BM . Reactive oxygen species are critical in the oleic acid-mediated mitogenic signaling pathway in vascular smooth muscle cells. Hypertension 1998; 32: 1003–1010.
Cernes R, Zimiichman R, Shargorodsky M . Arterial elasticity in cardiovascular disease: focus on hypertension, metabolic syndrome and diabetes. Adv Cardiol 2008; 45: 65–81.
Hansen TW, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006; 113: 664–670.
Feng TT, Chiuve SE, McCullough ML, Rexrode KM, Logroscino G, Hu FB . Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch Int Med 2008; 168: 713–720.
Khaw KT, Barrett-Connor E . Dietary potassium and stroke-associated mortality. A 12-year prospective population study. N Engl J Med 1987; 316: 235–240.
Khaw KT, Barrett-Connor E . Dietary fiber and reduced ischemic heart disease mortality rates in men and women: a 12-year prospective study. Am J Epidemiol 1987; 126: 1093–1102.
Garside PS, Gleuck CJ . The important role of modifiable dietary and behavioral characteristics in the causation and prevention of coronary heart disease hospitalization and mortality: the prospective NHANES I follow-up study. J Am Coll Nutr 1995; 14: 71–79.
Djoussé L, Arnett DK, Pankow JS, Hopkins PN, Province MA, Ellison RC . Dietary linolenic acid is associated with a lower prevalence of hypertension in the NHLBI Family Heart Study. Hypertension 2005; 45: 368–373.
Preli RB, Klein KP, Herrington DM . Vascular effects of dietary L-arginine supplementation. Atherosclerosis 2002; 162: 1–15.
Lekakis JP, Papathanassiou S, Papaioannou TG, Papamichael CM, Zakopoulos N, Kotsis V et al. Oral L-arginine improves endothelial dysfunction in patients with essential hypertension. Int J Cardiol 2002; 86: 317–323.
Castejon AM, Hoffmann IS, Jimenez E, Cubeddu RJ, Baldonedo RM, Cubeddu LX . Comparative effects of L-arginine infusion in obese hypertensive and lean normotensive: blood pressure, heart rate and insulin levels. J Hum Hypertens 2002; 16 (Suppl 1): S33–S36.
Engelhard YN, Gazer B, Paran E . Natural antioxidants from tomato extract reduce blood pressure in patients with grade-1 hypertension: a double-blind, placebo-controlled pilot study. Am Heart J 2006; 151: 100 (abstract).
Ward NC, Hodgson JM, Croft KD, Burke V, Beilin LJ, Puddey IB . The combination of vitamin C and grape-seed polyphenols increases blood pressure: a randomized, double-blind, placebo-controlled trial. J Hypertens 2005; 23: 427–434.
D'Uscio LV, Milstein S, Richardson D, Smith L, Katusic ZS . Long-term vitamin C treatment increases vascular tetrahydrobiopterin levels and nitric oxide synthase activity. Circ Res 2003; 92: 88–95.
Nosratola D, Vaziri D, Wang XQ, Oveisi F, Rad B . Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 2000; 36: 142–146.
Plantinga Y, Ghiadoni L, Magagna A, Giannarelli C, Franzoni F, Taddei S et al. Supplementation with Vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients. Am J Hypertens 2007; 20: 392–397.
Heller R, Werner-Felmayer G, Werner ER . Alpha-tocopherol and endothelial nitric oxide synthesis. Ann NY Acad Sci 2004; 1031: 74–85.
Ward NC, Wu JHY, Clarke MW, Puddey IB, Burke V, Croft KD et al. The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized,double-blind, placebo-controlled trial. J Hypertens 2007; 25: 227–234.
van Etten RW, de Koning EJ, Verhaar MC, Gaillard CA, Rabelink TJ . Impaired NO-dependent vasodilation in patients with type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate. Diabetologia 2002; 45: 1004–1010.
van Dijk RA, Rauwerda JA, Steyn M, Twisk JW, Stehouwer CD . Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebo-controlled trial. Arterioscler Thromb Vasc Biol 2001; 21: 2072–2079.
Forman JP, Rimm EB, Stampfer MJ, Curhan GC . Folate intake and the risk of incident hypertension among US women. JAMA 2005; 293: 320–329.
Doshi SN, McDowell IF, Moat SJ, Lang D, Newcombe RG, Kredan MB et al. Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide? Arterioscler Thromb Vasc Biol 2001; 21: 1196–1202.
Verhaar MC, Wever RM, Kastelein JJ, van Dam T, Koomans HA, Rabelink TJ . 5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation 1998; 97: 237–241.
Acknowledgements
We thank Kelley Martin, RD, MS, General Clinical Research Nutritionist, for her extraordinary efforts in assisting volunteers to comply with the study diets. We also thank the entire General Clinical Research Center staff for their dedication to the integrity of the research protocol as well as Kim Edwards for administrative support. This research was supported by grants from the National Institutes of Health (HL58794, HL04290), MD00267 from the National Center for Minority Health and Disparities, and the General Clinical Research Center (RR-01070) from the Division of Research Resources.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Al-Solaiman, Y., Jesri, A., Mountford, W. et al. DASH lowers blood pressure in obese hypertensives beyond potassium, magnesium and fibre. J Hum Hypertens 24, 237–246 (2010). https://doi.org/10.1038/jhh.2009.58
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2009.58
Keywords
This article is cited by
-
Association of priori-defined DASH dietary pattern with metabolic health status among Iranian adolescents with overweight and obesity
Scientific Reports (2024)
-
The association of dietary approaches to stop hypertension (DASH) with the odds of diabetic nephropathy and metabolic markers in women: a case–control study
BMC Women's Health (2023)
-
Association between dietary patterns and hypertension among Han and multi-ethnic population in southwest China
BMC Public Health (2018)
-
Associations of the dietary approaches to stop hypertension (DASH) diet with pregnancy complications in Project Viva
European Journal of Clinical Nutrition (2018)
-
Biochar reduces nitrate level in red beet
Environmental Science and Pollution Research (2018)